Lidak Pharm. [LDAKA] Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA]

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Zwiener who wrote (245)	7/9/1997 1:15:00 AM
From: luis a. garcia	of 1115

John here is what they recently reported on LMI... """ LIDAK's LMI technology is a novel proprietary approach to immunotherapy of cancer designed to stimulate tumor-specific killer cells, known as cytotoxic T lymphocytes (CTL), to combat invading tumor cells in the cancer-bearing host. In experimental laboratory models, LMI has been shown to stimulate increased CTL responses specific to a variety of tumor types and to improve the survival rates in cancer bearing mice. """ The phase two consisted in demonstrating succesfully the vaccine is safe for humans and is well tolerated.. The next phase will test its efficacy in killing tumor cells in humans.. and the protocol needs to be approved by the FDA etc.. I don't know offhand if they are at a point of readiness or if further development is required.. Its worth a call to the company ... luis

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next